HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Testosterone therapy for sexual dysfunction in postmenopausal women.

AbstractBACKGROUND:
After menopause, both surgical and natural, increases occur in the number of women experiencing sexual dysfunction. Although a direct link between sexual dysfunction and endogenous testosterone levels has not been clearly established, testosterone therapy is known to improve the signs and symptoms related to hypoactive sexual desire. However, testosterone supplementation is not approved in the United States for these clinical indications, primarily because of a lack of data evaluating the possible side-effects of these drugs.
METHOD:
A MEDLINE search was performed, with a priority for well-designed studies (randomized, controlled trials, meta-analysis), for published data related to the efficacy and safety of testosterone therapy in postmenopausal women.
RESULTS:
Randomized trials have demonstrated an improvement in sexual function with testosterone in postmenopausal women with hypoactive sexual desire disorder, particularly after oophorectomies. Side-effects have been well tolerated and reversible upon discontinuation.
CONCLUSION:
Exogenous testosterone treatment provides a rational therapeutic alternative to consider in women whose hypoactive sexual desire disorder negatively affects their quality of life and who have no biologic or psychosocial causes not related to decreased androgen levels for their sexual disorder. Women receiving testosterone should be monitored for clinical improvement and for adverse reactions. Transdermal patches and topical gels avoid the hepatic first-pass metabolism and are the preferred formulations. Testosterone therapy is usually administered concomitantly with estrogen therapy due to a lack of adequate safety and efficacy data on testosterone alone.
AuthorsZ Hubayter, J A Simon
JournalClimacteric : the journal of the International Menopause Society (Climacteric) Vol. 11 Issue 3 Pg. 181-91 (Jun 2008) ISSN: 1473-0804 [Electronic] England
PMID18568783 (Publication Type: Journal Article, Review)
Chemical References
  • Testosterone
Topics
  • Administration, Topical
  • Female
  • Humans
  • Libido (drug effects)
  • Middle Aged
  • Patient Satisfaction
  • Postmenopause
  • Randomized Controlled Trials as Topic
  • Sexual Behavior (drug effects)
  • Sexual Dysfunction, Physiological (drug therapy)
  • Testosterone (adverse effects, therapeutic use)
  • Treatment Outcome
  • Women's Health

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: